Zoledronic acid, an FPPS inhibitor, ameliorates liver steatosis through inhibiting hepatic de novo lipogenesis.

In conclusion, our data provide a novel application of ZA in improving hepatic steatosis.
PMID: 28843826 [PubMed - as supplied by publisher]

Source: European Journal of Pharmacology - August 23, 2017 Category: Drugs & Pharmacology Authors: Tang Q, Jiang S, Jia W, Shen D, Qiu Y, Zhao Y, Xue B, Li C Tags: Eur J Pharmacol Source Type: research